Kevin Schoemaker

Statistics

Publications

Citations

1.1K

H-Index

Active since

2008

Affiliations

Pathways Behavioral Services(Current)

Kevin Schoemaker is an author at Pathways Behavioral Services specializing in pi3k-akt signaling pathway, mtor inhibitor therapy, and pharmacodynamics of anticancer agents.

Publications per year

2008–2008

Publications

Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent <i>in vivo</i> antitumor activity

Sauveur-Michel Maira, Frédéric Stauffer, Josef Brueggen et al. · Molecular Cancer Therapeutics · 2008 · 1.1K citations · Full text

Medicine, Oncology, Pharmacology +13

1–1 of 1